Enhancing Pediatric TB Treatment Compliance: Marketing Strategies for Medication Reminder Devices
DOI:
https://doi.org/10.56988/chiprof.v4i3.96Keywords:
Health technology, Marketing strategy, Medication adherence, Medication Alarm, Pediatric tuberculosisAbstract
This research focuses on developing a marketing strategy for a medication reminder device (Alarm Obat) to improve medication adherence among children with tuberculosis (TB) in Indonesia. Tuberculosis remains a significant public health challenge, especially in pediatric populations, where adherence to long-term treatment regimens is critical for successful outcomes. The study explores how Alarm Obat, a device designed to remind children to take their medication on time, can help increase adherence and reduce treatment failures. The research also highlights the potential for this product to be integrated into healthcare programs, focusing on partnerships with healthcare institutions and digital marketing strategies. By targeting families with children suffering from TB, the research aims to demonstrate the impact of Alarm Obat on improving health outcomes and reducing the risk of drug resistance. The study concludes by emphasizing the importance of awareness campaigns and collaborative efforts to ensure accessibility and adoption of the product across diverse communities in Indonesia.
Downloads
References
J. K. Sharma, “Tuberculosis and comorbidities: A double burden in global health,” Indian J. Tuberc., vol. 72, no. S1, pp. S5–S6, 2025, doi: 10.1016/j.ijtb.2025.02.002.
Kemenkes RI, “Tuberculosis Control in Indonesia 2022,” 2022.
S. Soedarsono, N. M. Mertaniasih, T. Kusmiati, A. Permatasari, W. K. Ilahi, and A. T. Anggraeni, “Characteristics of Previous Tuberculosis Treatment History in Patients with Treatment Failure and the Impact on Acquired Drug-Resistant Tuberculosis,” Antibiotics, vol. 12, no. 3, pp. 4–13, 2023, doi: 10.3390/antibiotics12030598.
M. F. Sazali et al., “Improving Tuberculosis Medication Adherence: The Potential of Integrating Digital Technology and Health Belief Model,” Tuberc. Respir. Dis. (Seoul)., vol. 86, no. 2, pp. 82–93, 2023, doi: 10.4046/trd.2022.0148.
S. El-Rachidi, J. M. LaRochelle, and J. A. Morgan, “Pharmacists and pediatric medication adherence: Bridging the gap,” Hosp. Pharm., vol. 52, no. 2, pp. 124–131, 2017, doi: 10.1310/hpj5202-124.
T. H. Baryakova, B. H. Pogostin, R. Langer, and K. J. McHugh, “Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems,” Nat. Rev. Drug Discov., vol. 22, no. 5, pp. 387–409, 2023, doi: 10.1038/s41573-023-00670-0.
S. S. Chiang et al., “Adolescent, caregiver and provider perspectives on tuberculosis treatment adherence: A qualitative study from Lima, Peru,” BMJ Open, vol. 13, no. 5, pp. 1–12, 2023, doi: 10.1136/bmjopen-2022-069938.
T. Manyazewal et al., “Patient-reported usability and satisfaction with electronic medication event reminder and monitor device for tuberculosis: a multicentre, randomised controlled trial,” eClinicalMedicine, vol. 56, p. 101820, 2023, doi: 10.1016/j.eclinm.2022.101820.
R. Lester et al., “Mobile phone short message service for adherence support and care of patients with tuberculosis infection: Evidence and opportunity,” J. Clin. Tuberc. Other Mycobact. Dis., vol. 16, p. 100108, 2019, doi: 10.1016/j.jctube.2019.100108.
X. Liu et al., “Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial,” Lancet Glob. Heal., vol. 11, no. 5, pp. e693–e703, 2023, doi: 10.1016/S2214-109X(23)00068-2.
S. Charalambous et al., “Treatment adherence and clinical outcomes amongst in people with drug-susceptible tuberculosis using medication monitor and differentiated care approach compared with standard of care in South Africa: a cluster randomized trial,” eClinicalMedicine, vol. 75, p. 102745, 2024, doi: 10.1016/j.eclinm.2024.102745.
UNICEF, “Precision health : emerging innovations for children and adolescents,” 2024.
S. Lee, V. Rajaguru, J. S. Baek, J. Shin, and Y. Park, “Digital Health Interventions to Enhance Tuberculosis Treatment Adherence: Scoping Review,” JMIR mHealth uHealth, vol. 11, no. 1, pp. 1–12, 2023, doi: 10.2196/49741.
T. F. Soares Arnizant et al., “My Latent Tuberculosis Treatment - Mobile application to assist in adherence to latent tuberculosis treatment,” Procedia Comput. Sci., vol. 196, pp. 640–646, 2021, doi: 10.1016/j.procs.2021.12.059.
S. J. Iribarren et al., “Patient-centered mobile tuberculosis treatment support tools (TB-TSTs) to improve treatment adherence: A pilot randomized controlled trial exploring feasibility, acceptability and refinement needs,” Lancet Reg. Heal. - Am., vol. 13, p. 100291, 2022, doi: 10.1016/j.lana.2022.100291.
N. Bundogji, G. Toma, and A. Khan, “Identification of preferred reminder systems and patient factors to promote adherence in the management of urinary incontinence,” PEC Innov., vol. 1, no. July, p. 100067, 2022, doi: 10.1016/j.pecinn.2022.100067.
A. Sugiharto, L. C. Khoe, B. S. Sabarguna, and A. Pramastuty, “Reminder System as a Strategy to Improve Patient’s Adherence on Medical Appointment,” eJournal Kedokt. Indones., vol. 7, no. 1, 2019, doi: 10.23886/ejki.7.10303.
UNICEF, Desk Review: Pediatric Tuberculosis with a Focus on Indonesia. 2022.
A. M. Leddy et al., “Social Determinants of Adherence to Treatment for Tuberculosis Infection and Disease Among Children, Adolescents, and Young Adults: A Narrative Review,” J. Pediatric Infect. Dis. Soc., vol. 11, no. Suppl 3, pp. S79–S84, 2022, doi: 10.1093/jpids/piac058.
G. Fekadu et al., “Adherence to anti-tuberculosis treatment among pediatric patients at nekemte specialized hospital, Western Ethiopia,” Patient Prefer. Adherence, vol. 14, pp. 1259–1265, 2020, doi: 10.2147/PPA.S258292.
J. Aston, K. A. Wilson, and D. R. P. Terry, “The treatment-related experiences of parents, children and young people with regular prescribed medication,” Int. J. Clin. Pharm., vol. 41, no. 1, pp. 113–121, 2019, doi: 10.1007/s11096-018-0756-z.
M. Y. Tkela, M. Sambriong, and M. Kapitan, “Implementation of Alarm and Pill Reminder for Medication Adherence in Tuberculosis Patients,” J. Eduhealth, vol. 16, no. 01, pp. 271–277, 2025, doi: 10.54209/eduhealth.v16i01.
A. A. Malik, M. C. Becerra, and H. Hussain, “Ringing the alarm bell: Time to scale up drug-resistant tuberculosis preventive treatment,” EClinicalMedicine, vol. 34, p. 100821, 2021, doi: 10.1016/j.eclinm.2021.100821.
N. Solanki, P. Sharma, M. P. Rupani, and B. Goswami, “‘I lost my faith and stopped taking the medicines’ – need for an intervention model based on health belief constructs for improving adherence to tuberculosis treatment,” J. Fam. Med. Prim. Care, vol. 6, no. 2, pp. 169–170, 2022, doi: 10.4103/jfmpc.jfmpc.
M. Hamid et al., “Risk factors for unsuccessful tuberculosis treatment outcomes in children,” PLoS One, vol. 14, no. 9, pp. 1–8, 2019, doi: 10.1371/journal.pone.0222776.
Y. An et al., “Barriers to childhood tuberculosis case detection and management in Cambodia: the perspectives of healthcare providers and caregivers,” BMC Infect. Dis., vol. 23, no. 1, pp. 1–10, 2023, doi: 10.1186/s12879-023-08044-y.
L. C. Paul et al., “A smart medicine reminder kit with mobile phone calls and some health monitoring features for senior citizens,” Heliyon, vol. 10, no. 4, p. e26308, 2024, doi: 10.1016/j.heliyon.2024.e26308.
R. Mardhiyyah, S. Nuryadi, R. Ghifari, and A. Habibie, “IoT-Enabled Medication Reminder System with Alarm Delay Function,” Fidel. J. Tek. Elektro, vol. 6, no. 3, pp. 188–197, 2024, doi: 10.52005/fidelity.v6i3.234.
S. S. Fandinata, E. I. Lubada, N. M. Ulfa, and R. Darmawan, “Intervention Digital Medication Reminder App to Improve Hypertension Patient’s Self-Management Medication Adherence,” Str. J. Ilm. Kesehat., vol. 11, no. 2, pp. 117–125, 2022, doi: 10.30994/sjik.v11i2.926.
S. K. Saha, A. Adhikary, A. Jha, S. Saha, and B. Bora, “Probability of Medication Adherence When Alarm Is Used as a Reminder,” Int. J. Reliab. Qual. E-Healthcare, vol. 11, no. 1, pp. 1–16, 2022, doi: 10.4018/IJRQEH.305221.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Prahardian Putri, Mulyadi, Meliana, Yomi, Khairunnisa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
